Origin Energy (ASX: ORG) delivers A$911m APLNG dividend but flags FY27 decline as data breach exposes 900,000 customers
Read More Healthcare Industry News Boston Scientific (BSX) Q2 2026 beats estimates as MiRus TAVR investment reshapes strategy Boston Scientific lifted FY 2026 guidance and disclosed a $1.5B MiRus TAVR bet, but BSX trades near 52-week lows as softer Q3 growth guidance stings. byVenkateshJuly 29, 2026